Whole, normal extensor digitorum longus muscles (EDL) were orthtopically transplanted into transgenic mice, expressing nuclear localing b-galactosidase (nlsb-gal) under control of a muscle-specific promoter, in order to determine the extent to which nonmuscle derived, multipotent stem cells (which under experimental conditions exhibit myogenic potential) are spontaneously recruited from distal, nonmuscle organs to participate in the graft's regeneration. The host's contribution to the graft's regeneration was determined by evaluating the number and distribution of b-gal positive myonuclei in regenerated grafts. Fibers with b-gal positive nuclei accounted for B1% of the long-term (28-and 56-day) graft's myofibers. All were confined to the graft's periphery, adjacent to host's muscles. Failure to find myofibers with b-gal positive nuclei across the revascularized graft's girth demonstrated that there was no meaningful recruitment of nonmuscle stem cells from distal host organs, which must arrive at the graft via the circulation. Rather, stem cells residing in the graft at the time of transplantation accounted for B99.9% of the regenerated graft's myonuclei, with a minor contribution from the surrounding host muscles' myosatellite cells (that occurred when the epimysia of graft or host muscles were damaged during transplantation). The significance of these findings to gene therapy for Duchenne muscular dystrophy is discussed.
For many years skeletal muscle regeneration was believed to be entirely dependent on a resident population of muscle-specific stem cells. 1, 2 (myosatellite cells   3 ). In fact, the complement of myosatellite cells on a single isolated myofiber was recently shown to be sufficient to fully regenerate the parent myofiber within 4 days. 4 However, in progressive diseases of muscle (eg, Duchenne muscular dystrophy), where myosatellite cells are repeatedly stimulated to undergo mitosis and participate in the attempted regeneration of dystrophic muscle, the myosatellite cells become mitotically senescent, and muscle regeneration fails to keep pace with muscle degeneration. 5 Recently, a second type of stem cell, a multipotent stem cell, 6, 7 has been isolated from striated muscle. These cells can regenerate, among other tissues, bone marrow, 6 ,8 bone 7 and muscle. [6] [7] [8] [9] A small percentage of these multipotent stem cells, termed muscle side population (SP) cells 6 or muscle-derived stem cells (MDSC), 10 when injected directly into regenerating muscle, become incorporated into myofibers 6 and/or form myosatellite cells. 9 When injected into the vasculature of irradiated recipients, these cells can reconstitute the host's hematopoietic compartment and ultimately may become incorporated, albeit at low frequency, into regenerating muscle. 6 The relationship between MDSC and myosatellite cells is unclear. Pax7 deficient mice lack satellite cells, but contain muscle SP cells. 11 Normal muscle SP cells do not express desmin and Pax7, as do myosatellite cells. 9 They cannot form myotubes in vitro, unless they are co-cultured with normal myoblasts. 9 Whether MDSC are spontaneously recruited to participate during in vivo muscle regeneration has not been determined. What is known is that despite the presence of these cells in dystrophic muscle, dystrophic deterioration still occurs.
Adult stem cells capable of differentiation into multiple cell types, under experimental conditions, have been found in diverse organs. 12 These cells have the potential to treat a variety of diseases through ex vivo genetic manipulation and autologous transplantation. Given the wide distribution of skeletal muscle, the fact that it constitutes B30% of the body mass, and that progressive, degenerative disorders of skeletal muscle are characterized by repeated degeneration-regeneration cycles, it would be beneficial to return appropriately manipulated nonmuscle-derived stem cells to the organ from which it was initially isolated and then to utilize the circulatory system to deliver stem cells with myogenic potential to damaged or diseased muscles on an 'as needed' basis.
However, the extent to which these nonmusclederived stem cells are spontaneously recruited from their resident organs to participate in damaged or diseased muscle's growth or regeneration has not been quantified. It is known that bone marrow progenitors contribute to normal and dystrophic muscle regeneration under experimental conditions. 6, 13, 14 However, the extent of their contribution to dystrophic muscle does not prevent its deterioration. 15 Moreover, these progenitors have not been shown to contribute to the satellite cell population of regenerating muscles, 16 unless the muscle is irradiated to an extent that its endogenous myosatellite cells are drastically reduced or eliminated, 17 a technique not compatible with clinical practice. Meso-angioblasts, stem cells derived from the embryonic chick or mouse aorta, when implanted into regenerating adult chick muscle, can fuse with endogenous myosatellite cells to form mosaic myofibers. 18 It has been suggested, but not demonstrated, that meso-angioblasts may also be isolated from postnatal animals. 19 If meso-angioblasts persist in adult muscle, they, too, may be an appropriate candidate for ex vivo genetic manipulation. The present study is designed to determine whether meso-angioblasts or other nonmuscle-derived stem cells of adult animals can be spontaneously recruited to normal regenerating muscle, and, if so, to quantify the extent of their contribution.
Whole muscle transplantation is an accepted method of inducing massive degeneration-regeneration of skeletal muscle in adult animals. 1 Immediately following transplantation, the myofibers of the ischemic graft undergoes necrosis. The spatiotemporal pattern of phagocytotic removal of the necrotic myofibers and the replacement of these myofibers by de novo myotube formation occurs only after the graft begins to revascularize. Revascularization occurs from the graft's periphery and gradually moves toward the graft's center. Muscle regeneration follows revascularization, maintaining the same peripheral to central gradient. 20, 21 The transplantation model used for this study is appropriate, since the chosen host's genome contains a musclespecific transgene (encoding nlsb-gal) that is expressed in adult myofibers. Thus, host derived cells that participate in the graft's regeneration, regardless of their source, will contribute b-gal positive myonuclei to the regenerated normal graft. Moreover, if the host contributes bone marrow-derived stem cells or mesoangioblasts, they can only be delivered to the revascularized graft via the circulatory system, resulting in b-gal positive myonuclei across the revascularized graft's girth. In our study extreme care was taken not to damage the epimysia of the graft or host muscles during transplantation, since it had been shown that myosatellite cells from adjacent intact muscles can provide additional myosatellite cells to the damaged muscle to enhance regeneration, 22, 23 but only when the epimysia (connective tissue coverings) of the graft and intact muscles are compromised. 24 Nonetheless, if some damage did occur, one could anticipate finding a limited number of myofibers with b-gal positive nuclei confined to the periphery of the regenerated graft.
At the time of transplantation of the extensor digitorum longus muscle (EDL) of a normal mouse into an immunosuppressed LC3F nlacZ-E mouse, 25 the donor muscle's contained B1100 polygonally shaped myofibers 26 with peripheral myonuclei. Myofibers were regularly arranged into discrete fascicles (Figure 1a) . At 2 days post-transplantation, the graft was filled with rounded, swollen, necrotic myofibers, lacking fascicular arrangement (Figure 1b) . At 7 days post-transplantation, revascularization was completed in the graft's periphery, and small diameter myofibers, with central nuclei, were found in this region. The center of the 7-day graft contained small myotubes and remnants of the necrotic myofibers (not shown). Small diameter myotubes filled the center of the revascularized graft by 14 days posttransplantation (Figure 1c) .
By 28 days post-transplantation, the grafts (Figure 1d g; 2a-d) contained polygonal shaped myofibers, with many central myonuclei (Figure 1g ), organized into discrete fascicles (Figure 1d ). Grafts were distinguishable from the surrounding host muscle by the smaller size of their myofibers and the large number of b-gal positive, peripherally located myonuclei in fibers of the host's muscle (Figure 1d, f) . In contrast, the graft contained very few myofibers with b-gal positive myonuclei (Figure 1d , e; 2a-d). By following these myofibers in serial cryosections stained with X-gal (eg, Figure 2a-d) , it was determined that b-gal positive nuclei did not extend the full length of the fibers (ie, most fibers were mosaic, containing myonuclei derived from cells resident in the graft and host derived myonuclei). Grafted muscles contained 7.272 (mean7s.e.m.; range 2-11) mosaic myofibers. All myofibers containing b-gal positive myonuclei, save one of the 36 myofibers studied, were one or two fibers in from the graft's epimysium ( Figure  1e ; 2a-d). The remaining cell, which contained one b-gal positive nucleus, was found B6 myofibers in from the epimysium, in a connective tissue septa adjacent to a small blood vessel (Figure 2c ). Since we previously had shown that in mosaic myotubes two types of b-gal positive myonuclei were present -nuclei encoding nlsbgal and adjacent noncoding nuclei that had sequestered nlsb-gal produced by the encoding myonucleus(i) in the same fiber, 27 it is likely that this muscle cell was a mononucleated myocyte, rather than a multinucleated myotube. The total number of b-gal positive nuclei in the five grafts varied from 7 to 68 per graft (40.2715, mean7s.e.m.), including both host and adjacent donor derived myonuclei that appeared blue after reaction with X-gal. By following each fiber with a b-gal positive nucleus in serial sections (Figure 2a-d) , the number of positive myonuclei/myofiber was determined ( Figure  2e ). Most myofibers contained o6 b-gal positive myonuclei, but B14% of these cells were likely to be myocytes based on their single b-gal positive myonucleus.
Between 28-and 56 days after transplantation (compare Figure 1d , h), the mean myofiber diameter of the graft increased from 1870.4 to 2570.4 mm, which was still 31% less than that of age-matched control muscles. We had previously shown that long term EDL grafts had B31% fewer myofibers than age-matched control muscles, 26, 28 and that the grafts retained the fast phenotype characteristic of the normal murine EDL (which contains o1% slow myofibers). 29 The graft's fast phenotype ensures expression of the nlsb-gal transgene, which, in the present study, is under the control of a promoter preferentially expressed in fast myofibers. At 56 days after transplantation, the number of muscle cells with bgal positive nuclei/graft (6.372.1) was not significantly different from that found in 28-day grafted muscles, and B12% of these cells were myocytes, since they contained only one b-gal positive myonucleus ( Figure 2e ). As at 28-day post-transplantation, most of the myofibers contained o6 b-gal positive myonuclei (Figure 2e ). All cells Stem cells and muscle regeneration CH Washabaugh et al with b-gal positive nuclei remained confined to the graft's periphery, not more than 3-4 myofibers in from the grafted muscle's epimysium (Figure 1i ). Of the four grafts evaluated, three had less than 35 b-gal positive myonuclei while one had 103 of these nuclei (b-gal positive nuclei/graft ¼ 47721 (mean7s.e.m.)), including host derived b-gal encoding and donor derived noncoding myonuclei that had sequestered b-gal.
The absence of donor derived myonuclei in the center of our long-term grafts contradicts a previous study that found little evidence of host derived cells during the first few weeks after whole muscle transplantation, but extensive migration of host derived cells (myosatellite cells) into grafted muscles by 7-weeks after surgery. 23 However, in that study, the Tibialis Anterior (TA) and the EDL were jointly grafted. Since the TA lacks a discrete proximal tendon, removal of that muscle required cutting across the myofibers in the proximal region of the muscle, causing severe damage to the muscle and to its epimysium. ), which expresses nlsb-gal under the control of the myosin light chain 3F promoter and 3 0 enhancer, using a modification of the transplantation technique previously described. 29 Prior to transplantation the donor muscle was soaked for 20 min in 0.75% Marcaine s (Abbott Laboratories, North Chicago, IL, USA), a known myotoxic agent. 31 Care was taken to avoid damage to the epimysia of the donor muscle and the host muscles that formed the EDL bed. The donor muscle was sutured to the tendon stumps of the EDL of the host, maintaining its proximal-distal and superficial-deep orientations, and restoring the grafted muscles to their original lengths. Grafted muscles (n ¼ 4-5 grafts for each time period) were removed at 2 days and 1, 2, 4 and 8-weeks post-transplantation. Grafted muscles, age-matched control muscles, and host muscles were fixed in 2% paraformaldehyde, frozen in isopentane cooled liquid nitrogen and cut into serial, transverse, 8-mm-thick cryosections. A few sections along the muscles' lengths were reacted with hematoxylin and eosin. All remaining sections were reacted with X-gal 32 and counterstained with eosin, permitting the identification of all myofibers in each muscle, derived at least in part from host tissue, by the blue color of one or more of their myonuclei. Using an Optimas image analysis program (Optimas Corporation, Seattle, WA, USA), the cross-sectional area (at the widest girth) of each graft and of control muscles was measured, and the maximal diameter of 4250 randomly chosen myofibers in 28-and 56-day grafts and control muscles were measured. Differences in maximal cross-sectional areas and myofiber diameters were determined by analysis of variance (Microsoft Excel 2000 statistical package). Differences of Pp0.05 were regarded as significant. Results of morphometric analyses are included in text.
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Based on the number of myofibers with b-gal positive nuclei in long-term grafts (B1% of the graft's myofibers) and the peripheral location of these myofibers, we conclude as follows: (1 Figure 1 ) were used to determine the number of myotubes with b-gal positive myonuclei, the number of b-gal positive myonuclei/myofiber and the distribution of these nuclei throughout the muscle. To determine the number of myonuclei/mosaic myofiber, each myofiber containing a b-gal positive myonucleus was followed in serial sections along its length. Since myonuclei are B8 mm in length, nuclei in a single myofiber, found in the same region of that fiber in two successive sections, were counted as a single myonucleus.
Stem cells and muscle regeneration CH Washabaugh et al ments in which the epimysia of the host and donor muscles were purposely damaged during transplantation (not shown).) (3) Failure to find myofibres with b-gal positive nuclei across the graft's girth demonstrates that there is no meaningful, spontaneous recruitment of multipotent cells from distal host organs, that necessarily must arrive at the revascularized graft via the circulatory system.
That the contribution of host derived cells to the graft's regeneration was minimal can be best appreciated if we consider that long-term grafts of the EDL have B630 myofibers 28 and the number of myonuclei/ myofiber in the normal EDL is B273 4 (resulting in B170 000 nuclei in the muscle). We have shown that p0.03% of these myonuclei are b-gal positive in 56-day regenerated grafts, and this small percentage includes both host derived myonuclei as well as myonuclei derived from cells resident in the graft that sequestered nlsb-gal produced by the coding nuclei in the same myofiber. Therefore, it would appear that ex vivo genetic manipulation and autologous transplantation of nonmuscle-derived stem cells (with myogenic potential) back into the organ from which they were derived would only be a clinically significant therapeutic protocol, if techniques were developed that would ensure increased recruitment of these cells to the circulatory system for systemic delivery to diseased muscle.
